Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05457595
NA

Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies

Sponsor: CNAO National Center of Oncological Hadrontherapy

View on ClinicalTrials.gov

Summary

The study aims to obtain a local control rate in patients with lateral pelvic relapses of gynecologycal cancers previously irradiated. High LET (Linear Energy Transfer) particles as carbon ions can guarantee a biologic advantage compared to photons in radioresistant neoplasms, given to their higher biological efficacy (RBE).

Official title: Phase II Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

55

Start Date

2021-02-24

Completion Date

2028-02-25

Last Updated

2025-08-06

Healthy Volunteers

No

Interventions

RADIATION

carbon ion radiation therapy

CIRT: Planning Target Volume (PTV) will be delivered a total dose of 48-52.8 GyRBE in 12 fractions, 4 fractions per week. Treatment duration 3 weeks. Treatment lasting more than 5 weeks or cases of treatment with less than 6 fractions in 14 consecutive days will not be accepted.

Locations (1)

CNAO

Pavia, Pv, Italy